References

Results of coronary artery surgery in patients with poor left ventricular function (CASS)

10.1161/01.cir.68.4.785 · 1983 · External reference

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines

2022 · External reference

A standardized definition of ischemic cardiomyopathy for use in clinical research

10.1016/s0735-1097(01)01738-7 · 2002 · External reference

Arrhythmic and mortality outcomes among ischemic versus nonischemic cardiomyopathy patients receiving primary ICD therapy

10.1016/j.jacep.2021.06.020 · 2022 · External reference

Effect of carvedilol on survival in severe chronic heart failure

10.1056/nejm200105313442201 · 2001 · External reference

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

10.1056/nejm200004133421502 · 2000 · External reference

Prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA-an outcome study with up to 10 years of follow-up

10.1161/circimaging.122.014454 · 2023 · External reference

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

10.1161/01.cir.100.19.1992 · 1999 · External reference

Cardiovascular magnetic resonance assessment of human myocarditis

10.1161/01.cir.0000118493.13323.81 · 2004 · External reference

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy

10.1016/j.jacc.2004.03.035 · 2004 · External reference

Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction

10.1016/s0140-6736(00)03567-4 · 2001 · External reference

Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement

10.1016/j.jacc.2006.01.059 · 2006 · External reference

Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation

10.1161/hc2301.092121 · 2001 · External reference

Acute coronary findings at autopsy in heart failure patients with sudden death

10.1161/01.cir.102.6.611 · 2000 · External reference

Echocardiographic features of congestive cardiomyopathy compared with normal subjects and patients with coronary artery disease

10.1161/01.cir.49.6.1153 · 1974 · External reference

Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign

10.1016/s0735-1097(84)80392-7 · 1984 · External reference

Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy

10.1001/archinte.1992.00400160075014 · 1992 · External reference

Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction

10.1016/s1071-3581(03)00456-2 · 2003 · External reference

Noninvasive diagnosis of biopsy-proven cardiac amyloidosis

10.1016/j.jacc.2003.08.043 · 2004 · External reference

Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy

10.1007/bf02767044 · 1997 · External reference

Risk factors for the progression of coronary artery calcification in asymptomatic subjects

10.1161/circulationaha.106.674143 · 2007 · External reference

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

10.1056/nejm200011163432003 · 2000 · External reference

Myocardial viability

2006 · External reference

Relaxation of water protons in the intra‐ and extracellular regions of blood containing Gd(DTPA)

10.1002/mrm.1910030514 · 1986 · External reference

Extracellular space and ionic distribution in rat ventricle

10.1152/ajplegacy.1974.227.3.676 · 1974 · External reference

Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury

10.1161/hc0202.102016 · 2002 · External reference

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

10.1161/01.cir.56.5.786 · 1977 · External reference

Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy

10.1161/01.cir.0000095029.57483.60 · 2003 · External reference

Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients

10.1016/0002-8703(80)90663-8 · 1980 · External reference

Cardiomyopathic syndrome caused by coronary artery disease. III: Prospective clinicopathological study of its prevalence among patients with clinically unexplained chronic heart failure

10.1136/hrt.41.5.613 · 1979 · External reference

Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients

10.1016/0002-9149(87)90618-7 · 1987 · External reference

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

10.1161/01.cir.0000078641.19365.4c · 2003 · External reference

Recognition of the importance of embolization in atherosclerotic vascular disease

10.1161/01.cir.101.5.570 · 2000 · External reference

Mechanisms of plaque rupture mechanical and biologic interactions

10.1016/s0008-6363(98)00308-3 · 1999 · External reference

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy

10.1016/j.jacc.2006.07.049 · 2006 · External reference

Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy

10.1001/jama.2013.1363 · 2013 · External reference

Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance

10.1016/j.jacc.2004.11.037 · 2005 · External reference

The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis

10.1016/j.jjcc.2008.03.002 · 2008 · External reference

Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement

10.1016/j.jcmg.2018.07.015 · 2019 · External reference

Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study

2020 · External reference

Ringlike late gadolinium enhancement provides incremental prognostic value in non-classical arrhythmogenic cardiomyopathy

10.1186/s12968-023-00986-1 · 2023 · External reference

Ring-like late gadolinium enhancement: differential diagnosis and mimics

10.1590/0100-3984.2024.0111 · 2025 · External reference

Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation

10.1093/ehjci/jead184 · 2023 · External reference

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation

10.1093/eurheartj/ehx596 · 2017 · External reference

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy

10.1186/1532-429x-13-30 · 2011 · External reference

Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction

10.1080/10976640701693733 · 2007 · External reference

Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies

10.1016/j.nmd.2008.03.012 · 2008 · External reference

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy

10.1186/1532-429x-12-68 · 2010 · External reference

Features of myocardial injury detected by cardiac magnetic resonance in a patient with desmin-related restrictive cardiomyopathy

10.1002/ehf2.13624 · 2021 · External reference

Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

10.1016/s0735-1097(02)02602-5 · 2002 · External reference

Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy

2002 · External reference

Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance

10.1016/s0735-1097(03)00189-x · 2003 · External reference

Delayed hyper‐enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances

10.1002/jmri.20172 · 2004 · External reference

Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy

10.1016/j.mri.2003.08.009 · 2004 · External reference

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I

10.1136/hrt.2004.041384 · 2005 · External reference

Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy

10.1097/00004728-200605000-00011 · 2006 · External reference

Clinical significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy

10.1157/13097921 · 2007 · External reference

Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy

10.1016/j.ijcard.2007.06.023 · 2008 · External reference

Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications

10.1016/j.cardfail.2008.02.006 · 2008 · External reference

Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients

10.1016/j.hlc.2008.03.080 · 2008 · External reference

Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy

10.1161/circulationaha.113.007094 · 2014 · External reference

Subendocardial involvement as an underrecognized LGE subtype related to adverse outcomes in hypertrophic cardiomyopathy

10.1016/j.jcmg.2023.03.011 · 2023 · External reference

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease evidence for a disease specific abnormality of the myocardial interstitium

10.1016/j.ehj.2003.09.017 · 2003 · External reference

The variation of morphological and functional cardiac manifestation in fabry disease: potential implications for the time course of the disease

10.1093/eurheartj/ehi143 · 2005 · External reference

Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in fabry’s cardiomyopathy

10.1016/j.amjcard.2005.11.087 · 2006 · External reference

Cardiac magnetic resonance in fabry disease: morphological, functional, and tissue features

10.3390/diagnostics12112652 · 2022 · External reference

Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy

10.1016/j.jacc.2006.10.078 · 2007 · External reference

Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach

10.1186/1532-429x-10-50 · 2008 · External reference

Late gadolinium enhancement: precursor to cardiomyopathy in duchenne muscular dystrophy?

10.1007/s10554-008-9352-y · 2008 · External reference

Diagnostic and prognostic value of cardiovascular magnetic resonance in neuromuscular cardiomyopathies

10.1007/s00246-021-02686-y · 2022 · External reference

Cardiovascular magnetic resonance in cardiac amyloidosis

10.1161/01.cir.0000152819.97857.9d · 2005 · External reference

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance

10.1136/hrt.2005.061911 · 2005 · External reference

Magnetresonanztomografie bei kardialer amyloidose–morphologie, funktion und late enhancement

2008 · External reference

Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis

10.1016/j.jacc.2007.10.049 · 2008 · External reference

Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis

10.1161/circulationaha.115.016567 · 2015 · External reference

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis

10.1186/1532-429x-14-s1-o87 · 2012 · External reference

CMR-based differentiation of AL and ATTR cardiac amyloidosis

10.1016/j.jcmg.2013.08.015 · 2014 · External reference

Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis

10.1016/j.jcmg.2022.10.018 · 2023 · External reference

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

10.1161/circulationaha.105.606509 · 2006 · External reference

Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study

10.1016/j.jacc.2017.08.044 · 2017 · External reference

Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging

10.1148/radiol.2371041322 · 2005 · External reference

Value of MRI in patients with a clinical suspicion of acute myocarditis

10.1007/s00330-007-0612-3 · 2007 · External reference

Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence

10.1148/radiol.2461062179 · 2008 · External reference

Cardiac MRI features and prognostic value in immune checkpoint inhibitor-induced myocarditis

10.1148/radiol.211765 · 2022 · External reference

Cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy–a real-world observational study

2025 · External reference

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

10.1093/eurheartj/ehaa051 · 2020 · External reference

Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease

10.1016/j.jacc.2005.06.067 · 2005 · External reference

Left ventricular scar and prognosis in chronic Chagas cardiomyopathy

10.1016/j.jacc.2018.09.035 · 2018 · External reference

Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance

10.1186/s12968-015-0200-7 · 2015 · External reference

Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance

10.1016/j.ijcard.2011.07.089 · 2013 · External reference

Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy

10.1016/j.jacc.2018.08.2195 · 2018 · External reference

Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach

10.1177/0961203308089401 · 2008 · External reference

The presence, location, and degree of late gadolinium enhancement in relation to myocardial dysfunction and poor prognosis in patients with systemic lupus erythematosus

10.3390/jcdd10110451 · 2023 · External reference

Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features

10.1177/0961203320936748 · 2020 · External reference

Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study

10.1177/0961203315622275 · 2016 · External reference

Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus

10.1007/s10554-023-02970-3 · 2024 · External reference

Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study

10.1002/art.22971 · 2007 · External reference

Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis

10.3899/jrheum.080377 · 2009 · External reference

Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imaging

2008 · External reference

Cardiac involvement in systemic sclerosis and the value of late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR)

10.1093/eurheartj/eht309.p2999 · 2013 · External reference

Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging

10.1093/eurheartj/ehn433 · 2008 · External reference

Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy

10.1001/jama.2011.992 · 2011 · External reference

Patterns of late gadolinium enhancement in chronic hemodialysis patients

10.1016/j.jcmg.2008.03.011 · 2008 · External reference

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging

10.1038/sj.ki.5000249 · 2006 · External reference

Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis

10.1136/hrt.2005.079392 · 2006 · External reference

The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis

10.1016/j.jcmg.2019.03.029 · 2020 · External reference

Myocardial scar and mortality in severe aortic stenosis

10.1161/circulationaha.117.032839 · 2018 · External reference

Myocardial scar and remodelling predict long-term mortality in severe aortic stenosis beyond 10 years

10.1093/eurheartj/ehae067 · 2024 · External reference

LGE prevalence and patterns in severe aortic stenosis: when “junctional” means the same

10.1016/j.ijcard.2023.02.034 · 2023 · External reference

Cardiovascular magnetic resonance imaging detects cardiac involvement in churg-strauss syndrome

10.1016/j.cardfail.2008.07.227 · 2008 · External reference

Cardiac magnetic resonance imaging findings in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a systematic review

10.1002/acr2.70026 · 2025 · External reference

Churg–strauss syndrome-associated heart failure and left ventricular thrombosis

10.1002/ehf2.14244 · 2023 · External reference

Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-strauss syndrome

10.1161/circulationaha.107.721738 · 2008 · External reference

MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels

2007 · External reference

Association of HIV infection with cardiovascular pathology based on advanced cardiovascular imaging: a systematic review

10.1001/jama.2022.15078 · 2022 · External reference

Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients

10.1161/circimaging.115.004091 · 2016 · External reference

Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension

10.1016/j.amjcard.2007.03.094 · 2007 · External reference

Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry

10.1186/1532-429x-14-40 · 2012 · External reference

LGE patterns in pulmonary hypertension do not impact overall mortality

10.1016/j.jcmg.2014.08.014 · 2014 · External reference

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension

10.1186/1532-429x-14-11 · 2012 · External reference

Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging

10.1007/s00330-008-1067-x · 2008 · External reference

Peripartum cardiomyopathy: diagnostic and prognostic value of cardiac magnetic resonance in the acute stage

10.3390/diagnostics12020378 · 2022 · External reference

Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping

10.1186/s12968-019-0590-z · 2020 · External reference

Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy

10.1161/jaha.117.005472 · 2017 · External reference

Myocardial damage assessed by late gadolinium enhancement on cardiovascular magnetic resonance imaging in cancer patients treated with anthracyclines and/or trastuzumab

10.1093/ehjci/jeaa279 · 2020 · External reference

A new typical finding in late gadolinium enhanced images for the diagnosis of endomyocardial fibrosis-the double V sign

10.1186/1532-429x-13-s1-o40 · 2011 · External reference

Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients

10.1161/circimaging.110.950675 · 2011 · External reference

Comprehensive assessment of endomyocardial fibrosis with cardiac mri: morphology, function, and tissue characterization

10.1148/rg.2020190148 · 2020 · External reference

Two different clinical presentations and stages of loeffler endocarditis diagnosed by multimodality investigations

10.1016/j.case.2023.09.003 · 2023 · External reference

Loeffler’s endocarditis: an integrated multimodality approach

10.1016/j.echo.2020.09.002 · 2020 · External reference

Follow-up CMR in a case of loeffler endocarditis

10.1002/ccr3.3582 · 2021 · External reference

2023 ESC guidelines for the management of cardiomyopathies

10.1093/eurheartj/ehad194 · 2023 · External reference

Patients with acute myocarditis following mRNA COVID-19 vaccination

10.1001/jamacardio.2021.2828 · 2021 · External reference

Prognostic value of nonischemic ringlike left ventricular scar in patients with apparently idiopathic nonsustained ventricular arrhythmias

10.1161/circulationaha.120.047640 · 2021 · External reference

Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy—an expert consensus document of the European association of cardiovascular imaging

10.1093/ehjci/jew229 · 2017 · External reference

Gadolinium-enhancedmagnetic resonance imagingin hypertrophic cardiomyopathy

10.1016/s0735-1097(03)00190-6 · 2003 · External reference

Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis

10.1093/ehjci/jeu182 · 2014 · External reference

Detection of myocardial damage in patients with sarcoidosis

10.1161/circulationaha.109.851352 · 2009 · External reference

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

10.1093/eurheartj/ehi258 · 2005 · External reference

Intravascular ultrasound analysis of infarct-related and non–infarct-related arteries in patients who presented with an acute myocardial infarction

10.1161/01.cir.0000072768.80031.74 · 2003 · External reference

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult

2005 · External reference

Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology

10.1161/circulationaha.110.011346 · 2011 · External reference

Nonischemic or dual cardiomyopathy in patients with coronary artery disease

10.1161/circulationaha.123.067032 · 2024 · External reference

Identifying the infarct-related artery in patients with non-ST-segment-elevation myocardial infarction

10.1161/circinterventions.118.007305 · 2019 · External reference

10.1016/j.ahj.2013.09.012

10.1016/j.ahj.2013.09.012 · 2013 · External reference

Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association

10.1161/cir.0000000000000670 · 2019 · External reference